Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension

Hypertension

Volumn 27, Issue 1, 1996, Pages 85-89

  Chen, Ke ^a   Zhang, Xuewei ^a   Dunham, Earl W ^a   Zimmerman, Ben G ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

captopril; desoxycorticosterone; kallikrein kinin system; rats, inbred strains

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; CAPTOPRIL; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; KALLIKREIN; KININ; LOSARTAN; RENIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; KALLIKREIN KININ SYSTEM; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; UNINEPHRECTOMY;

EID: 0030067953     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.1.85     Document Type: Article

References (23)

1. Carretero OA, Scicli AG. The renal kallikrein-kinin system. Am J Physiol. 1980;238:F247-F255.
2. Carretero OA, Scicli AG. Local hormonal factors (intracrine, autocrine, and paracrine) in hypertension. Hypertension. 1991; 18(suppl I):I-58-I-69.
3. Nolly H, Carretero OA, Lama MC, Miatello R, Scicli AG. Vascular kallikrein in deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 1994;23(suppl I):I-185-I-188.
4. Madeddu P. Varoni MV, Demontis MP, Fattaccio MC, Parpaglia PP, Glorioso N. A kallikrein-like enzyme in the aorta of normotensive and hypertensive rats. Hypertension. 1994;23:899-902.
5. Geller GE, Margolius HS, Pisano JJ, Keiser HR. Effects of mineralocorticoids, altered sodium intake and adrenalectomy on urinary kallikrein in rats. Circ Res. 1972;31:857-861.
6. Margolius HS, Horwitz D, Geller RG, Alexander RW, Gill JR, Pisano JJ, Keiser HR. Urinary kallikrein excretion in hypertensive man: relationships to sodium intake and sodium retaining steroids. Circ-Res. 1974;35:820-825.
7. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kullikreins, kininogens, and kininases. Pharmacol Rev. 1992;44:1-80.
8. Keiser HR, Geller RG, Margolius HS, Pisano JJ. Urinary kallikrein in hypertensive animal models. Fed Proc. 1976;35:199-202.
9. Rubin B, Antonaccio MJ, Horovitz ZP. Captopril (SQ 14,225) (D-3-mercapto-3-methylpropanoyl-L-proline): a novel orally active inhibitor of angiotensin converting enzyme and antihypertensive agent. Prog Cardiovasc Dis. 1978;21:184-194.
10. Douglas BH, Langford HG, McCaa RE. Response of mineralocorticoid hypertensive animals to an anciotensin I converting enzyme inhibitor. Proc Soc Exp Biol Med. 1979;161:86-87.
11. Wada T, Kanagawa R, Yoshimasa I, Inada Y, Nishikawa K. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats. J Hypertens. 1995;13: 113-122.
12. Marks ES, Bing RF, Thurston H, Swales JD. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14,225): the role of factors other than renin-angiotensin blockade in the rat. Clin Sci. 1980;58:1-6.
13. Miyamori I, Brown MJ, Dollery CT. The effect of captopril on blood pressure and plasma renin activity of DOCA-salt hypertensive rats: inhibition of the hypertensive response by indomethacin. Clin Exp Hypertens. 1980;2:935-945.
14. Carretero OA. High-mineralocorticoid conditions: kinins (paracrine hormones) in the regulation of renal function and blood pressure. In: Mornex R, Jaffiol C, Leclere J, eds. Progress in Endocrinology. Proceedings of the Ninth International Congress of Endocrinology, Nice 1992. London, UK: Parthenon; 1993;536-540.
15. Wong PC, Zimmerman BG. Dependence of renal vasodilator effect of captopril on prevailing plasma renin level in the dog: influence of DOCA-salt treatment. Clin Sci. 1982;63:355-360.
16. Hollenberg NK, Coletti C, Passan D. Hypertension, volume and vasoconstriction: studies on the renal blood supply in SHR, WKY, and DOCA-salt rat models. Hypertens Res. 1992;15:3-11.
17. Majima M, Katori M, Hanazuka M, Mizogami S, Nakano T. Nakao Y, Mikami R, Uryu H, Okamura R, Mohsin SSJ, Oh-Ishi S. Suppression of rat deoxycorticosterone-salt hypertension by kallikrein-kinin system. Hypertension. 1991;17:806-813.
18. Madeddu P, Anania V, Parpaglia PP, Demontis MP, Varoni MV, Fattaccio MC, Glorioso N. Chronic kinin receptor blockade induces hypertension in desoxycorticosterone-treated rats. Br J Pharmacol. 1993;108:651-657.
19. Bao G, Gohlke P, Qadri F, Unger T. Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension. 1992;20:74-79.
20. Zimmerman BG, Mommsen C, Kraft E. Renal vasodilatation caused by captopril in conscious normotensive and Goldblatt hypertensive does, Proc Soc Exp Biol Med. 1980;164:459-465.
21. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PBMWM. Nonpeptide angiotensin II receptor antagonists, VIII: characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. J Pharmcol Exp Ther. 1990;252:719-725.
22. Ha H, Dunham EW. Limited capacity for renal vasodilatation in anesthetized diabetic rats. Am J Physiol. 1987;253:H845-H855.
23. Nakagawa M, Nasjletti A. Renal function as affected by inhibitors of kininase II and of neutral endopeptidase 24.11 in rats with and without deoxycorticosterone pretreatment. Agents Action. 1991;247: 495-499.